During the past decade, Capital Eye Specialists conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Capital Eye Specialists" are "Glaucoma, Open-Angle" (1 trials), "Ocular Hypertension" (1 trials) and "Open Angle Glaucoma" (1 trials). Many other conditions were trialed in "Capital Eye Specialists" in a lesser frequency.

Most popular intervention types in "Capital Eye Specialists" are "Drug" (2 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Active Comparator: Timolol 0.5%" (1 trials), "Bimatoprost SR" (1 trials), "ONL1204 Ophthalmic solution (Dose A)" (1 trials), "ONL1204 Ophthalmic solution (Dose B)" (1 trials) and "Sham procedure" (1 trials). Other intervention names were less common.

The vast majority of trials in "Capital Eye Specialists" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Capital Eye Specialists". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Capital Eye Specialists, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Capital Eye Specialists, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".